Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Conditional Labeling

NCT03884231 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03884231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03884231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-Market Study Evaluating the Safety of Infinity DBS System With MR Conditional Labeling
Lead sponsor
Abbott Medical Devices
Phase
Observational
Overall status
Completed
Start date
April 10, 2019
Completion date
August 20, 2021
Enrollment
74 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

dystonia, essential tremor, movement disorders, parkinson disease, tremor